Propanc Biopharma is a biopharmaceutical company based in Melbourne, Australia. The company is focused on developing new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers. Their lead product, PRP, is a formulation that aims to prevent the recurrence and metastasis of cancer after surgery by addressing the root cause of cancer recurrence.

Propanc Biopharma is a public company listed on the OTC market and is engaged in extensive research and clinical development of its products. Through a scientific and research-based approach, Propanc is striving to provide effective treatment options for patients with a focus on improving quality of life and survival outcomes. Their work is guided by a team of experts who bring a wealth of experience in the pharmaceutical and biotechnology industries.

Connect